Search

You searched for "clinics"

2667 results found
JAAPOS journal cover image.

How common is ocular trauma in children and what are the clinical features?

3 April 2024 | | EYE - Paediatrics, EYE - Strabismus
The authors present a multicenter retrospective case review with the aim of reporting the incidence and characteristics of paediatric ocular trauma. Records for individuals aged 18 and under with a diagnosis of globe, orbit or adnexal injury over a 10-year...

SAVE THE DATE - Optos Peer Discussion Webinar

13 April 2023 | Research & Development
‘Working with ultra-widefield multi-modality retinal imaging: the clinical and practical value this technology adds to your ophthalmology clinic.’

Diabetic retinopathy screening in Belize: a country’s journey towards reducing blindness from DR

1 February 2019 | | EYE - Vitreo-Retinal, EYE - General
The rise of diabetes mellitus (DM) and its complications is a public health concern in the Caribbean. The Caribbean Diabetic Retinopathy (DR) Programme, managed by the London School of Hygiene & Tropical Medicine (LSHTM) and funded by the Queen Elizabeth...

SightCare Awards 2026 – shortlisted practices revealed

26 March 2026 | industry news, awards, optometry
SightCare is delighted to announce the shortlisted practices for the SightCare Awards 2026, celebrating excellence, innovation and impact across the independent optical sector. The awards will take place as part of SightCare LIVE 2026, with a glittering black-tie gala dinner...
Eye journal cover image.

Fingolimod: ocular adverse effects

1 October 2017 | | EYE - Vitreo-Retinal
In this article the authors review the ocular side-effects of Fingolimod which is an oral immunomodulating drug used in the management of relapsing-remitting multiple sclerosis (RRMS). Fingolimod-associated macular oedema (FAME) is the most common ocular side-effect linked to this drug....

A trip up north: Eye News Symposium 2020

24 February 2020
New accents, friendly smiles and haggis served with my traditional morning breakfast, I knew at this point that I was a long way from the south of England, where this story begins.

UK Paediatric Glaucoma Society Annual Meeting 2025

24 January 2025
by Hussain Aluzri, Junior Glaucoma Cinical Research Fellow, Birmingham Midland Eye Centre, UK. The UKPGS 2025 conference was another resounding success, held on 24 January 2025 at the Cavendish Conference Centre, London. The event commenced with an opening address by...

Pharma chameleon

3 April 2024 | | EYE - General
One morning in September ’95, about a month into my first house job on the South Coast of England, I emerged from the ridiculously early ward round on the coronary care unit feeling a bit dazed and therefore headed off...

World-class centre for eye health reaches construction milestone

28 January 2025 | Construction, research, Oriel, london
The new home for Moorfields Eye Hospital NHS Foundation Trust and the UCL Institute of Ophthalmology reached a significant construction milestone today. The completion of the concrete structure as part of the new centre for advancing eye health in St...

Real-world experience and outcomes of SLT laser used as a first-line treatment in ocular hypertension patients in a United Kingdom National Health Service setting

3 October 2022 |
The management of raised intraocular pressure (IOP) in the context of ocular hypertension (OHT) and primary open angle glaucoma (POAG) remains a major contributor to the workload of ophthalmology units across the UK. Treatment of these conditions has historically centred...

The results of the last survey Jun23

5 June 2023 | | EYE - General
*Please be aware that this data does not form part of a peer reviewed research study. The information therein should not be relied upon for clinical purposes but instead used as a guide for clinical practice and reflection. I continue...

Broadening of treatment options for potentially blinding retinal conditions

2 August 2022 | | EYE - General
Rod McNeil provides an update on a promising bispecific antibody recently approved for treatment of neovascular age-related macular degeneration (nAMD) and diabetic macular oedema (DMO) and considers emerging developments in biosimilars to established anti-vascular endothelial growth factor (anti-VEGF) therapies, including...